CLINICAL_TRIALS
trial_result
· 2025-08-27
Clinical Trial Update: Esgliteo Post Marketing Surveillance (PMS) in Korean Patients With Type 2 Diabetes Mellitus
Summary
Post-marketing surveillance results for Esgliteo in Korean patients with Type 2 diabetes mellitus have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2025-08-27